Table 3 Sensitivity, specificity, PPV, NPV, and accuracy in predicting degree of dysplasia in patients with IPMN

HGD

MPD ≥ 10 mm

57.1%

80.0%

33.3%

91.4%

76.6%

Jaundice

14.3%

82.5%

12.5%

84.6%

72.3%

Tuberous enhancement

42.9%

80.0%

27.3%

88.9%

74.5%

AP

57.1%

82.5%

36.4%

91.7%

78.7%

IC

MPD ≥ 10 mm

40.0%

78.4%

33.3%

82.9%

70.2%

Jaundice

50.0%

91.9%

62.5%

87.2%

83.0%

Tuberous enhancement

30.0%

78.4%

27.3%

80.6%

68.1%

AP

20.0%

75.7%

18.2%

77.8%

63.8%

Malignant (HGD + IC)

MPD ≥ 10 mm

47.1%

86.7%

66.7%

74.3%

72.3%

Jaundice

35.3%

93.3%

75.0%

71.8%

72.3%

Tuberous enhancement

35.3%

83.3%

54.5%

69.4%

66.0%

AP

35.3%

83.3%

54.5%

69.4%

66.0%

Intestinal epithelial subtype

MPD ≥ 10 mm

55.6%

81.6%

41.7%

88.6%

76.6%

Jaundice

33.3%

86.8%

37.5%

84.6%

76.6%

Tuberous enhancement

33.3%

78.9%

27.3%

83.3%

70.2%

AP

33.3%

78.9%

27.3%

83.3%

70.2%